A novel gut-restricted small molecule TLR2 agonist enhances immune checkpoint inhibitor efficacy in a preclinical mouse fibrosarcoma tumor model. (October 2022) - Simon, J.; Oalmann, C.J.; Stern, P.; Senter, R.K.; Chien, M.; Graf, R.; Bessede, A.; Campbell, A.S.